Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance

MT Newswires Live

May 07

Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.

Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.

Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533462266"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533462266\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533462266?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 11:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533462266","market":"hk","top_or_hot":-1,"title":"Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance","media":"MT Newswires Live","content":"<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlthea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-07 11:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533462266","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533462266","pubTimestamp":1746589005,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Althea Group Holdings  has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","AGH.AU":"ALTHEA GROUP HOLDINGS LTD","BK7502":"大麻概念"},"translate_title":"Althea Group Holdings出售制药部门，撤回2025财年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGH.AU":0.9},"content_text":"Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}